These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 31787414

  • 21. Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
    Bellier L, Petitjean A, Sarazu T, Tresierra J, Lopez JG.
    Vaccine; 2021 Jul 05; 39(30):4144-4152. PubMed ID: 34130885
    [Abstract] [Full Text] [Related]

  • 22. Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model.
    Crépey P, Boiron L, Araujo RR, Lopez JG, Petitjean A, de Albuquerque Luna EJ.
    BMC Public Health; 2020 Sep 09; 20(1):1374. PubMed ID: 32907562
    [Abstract] [Full Text] [Related]

  • 23. Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population.
    Tavares D, Mouriño H, Rodríguez CA, Saborido CM.
    Vaccines (Basel); 2022 Aug 09; 10(8):. PubMed ID: 36016173
    [Abstract] [Full Text] [Related]

  • 24. Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey.
    Amiche A, Tanriover MD, Bellier L, Ugur B, Akin L.
    Value Health Reg Issues; 2021 Sep 09; 25():15-22. PubMed ID: 33485248
    [Abstract] [Full Text] [Related]

  • 25. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
    Hendriks J, Hutubessy RCW, Grohmann G, Torelli G, Friede M, Kieny MP.
    Vaccine; 2018 Jun 27; 36(28):3993-3997. PubMed ID: 29866617
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate.
    Nham E, Seong H, Hyun H, Yoon JG, Noh JY, Cheong HJ, Kim WJ, Kim E, Choi L, Lee JM, Song JY.
    Hum Vaccin Immunother; 2023 Dec 15; 19(3):2266233. PubMed ID: 37964587
    [Abstract] [Full Text] [Related]

  • 27. Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis.
    Bianculli PM, Bellier L, Mangado IO, Pérez CG, Mieres G, Lazarov L, Petitjean A, Dibarboure H, Lopez JG.
    Hum Vaccin Immunother; 2022 Nov 30; 18(5):2050653. PubMed ID: 35344679
    [Abstract] [Full Text] [Related]

  • 28. Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types.
    Van Bellinghen LA, Marijam A, Tannus Branco de Araujo G, Gomez J, Van Vlaenderen I.
    Braz J Infect Dis; 2018 Nov 30; 22(1):1-10. PubMed ID: 29352897
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    van de Witte S, Nauta J, Montomoli E, Weckx J.
    Vaccine; 2018 Sep 25; 36(40):6030-6038. PubMed ID: 29709447
    [Abstract] [Full Text] [Related]

  • 33. Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China.
    Gong Y, Yao X, Peng J, Ma Y, Fang Y, Yan K, Jiang M.
    Am J Prev Med; 2023 Jul 25; 65(1):155-164. PubMed ID: 37037733
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM, Weidemann F, Damm O, Ultsch B, Greiner W, Wichmann O.
    Value Health; 2021 Jan 25; 24(1):32-40. PubMed ID: 33431151
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.
    Jamotte A, Chong CF, Manton A, Macabeo B, Toumi M.
    BMC Public Health; 2016 Jul 22; 16():630. PubMed ID: 27449665
    [Abstract] [Full Text] [Related]

  • 40. Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
    Wong C, Jiang M, You JH.
    PLoS One; 2016 Jul 22; 11(12):e0169030. PubMed ID: 28006012
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.